Cited by 317Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

7. Diabetes Technology: Standards of Care in Diabetes — 2023

Open access
ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E. +12 more·2023·Diabetes Care

Abstract

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc23-s007

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other people with diabetes do not require routine blood glucose monitoring, other than during pregnancy, although monitoring may be informative in the setting of dietary changes, changes to physical activity or drug therapy, or if glycaemic metrics are not at target.

    “Other people do not require routine blood glucose monitoring, other than during pregnancy, although monitoring in the setting of dietary changes, changes to physical activity or drug therapy,4 or if glycaemic metrics are not at target, may be informative.”

    From Blood glucose monitoring devices: current considerations (2023) · cites this paper as [4]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Guidelines recommend continuous glucose monitors are offered to all patients with type 1 or type 2 diabetes using multiple daily injections or insulin pump therapy who are capable (or whose caregiver is capable) of using the device.

    “Guidelines recommend continuous glucose monitors are offered to all patients with type 1 or type 2 diabetes using multiple daily injections or insulin pump therapy who are capable (or whose caregiver is capable) of using the device.4”

    From Blood glucose monitoring devices: current considerations (2023) · cites this paper as [4]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

6 of the 258 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Herman A, Aerts O, Baeck M, et al. Allergic contact dermatitis caused by isobornyl acrylate in Freestyle Libre, a newly introduced glucose sensor. Contact Dermat 2017;77:367-373 114.

Cited by

Sorted by citations

Authors
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
Venue
Diabetes Care
Published
2022-12-12
Volume
46
Issue
Supplement_1
Pages
S111-S127
ISSN
0149-5992 (ISSN-L)
OpenAlex
W4311264017
Cited by
301
References
258
Citations by year
2026: 20 · 2025: 55 · 2024: 132 · 2023: 93 · 2022: 1
FWCI
10.00
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
diabetes technology, diabetes management, clinical guidelines, quality of care, treatment goals
MeSH terms
Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review